prof. dr. Fritz Offner
Show
Sort by
-
Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity in patients with relapsed/refractory follicular or 'aggressive' lymphoma
-
The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure
-
Aspiration pneumonia : an underestimated cause of severe respiratory failure in patients with haematological malignancies and severe oral mucositis?
-
Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies
-
The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562
-
Anti-CD22 immunoconjugate inotuzumab ozogamicin (CMC-544) + rituximab: clinical activity including survival in patients with recurrent/refractory follicular or 'aggressive' lymphoma
-
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
-
Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia
-
Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia
-
Chronic Lymphocytic Leukaemia